Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Parks: Replicating Viral Vaccine Vectors |
| Strategy: | Vector vaccines (viral or bacterial) |
| Study Type: | Pre-Clinical NHP |
| Species: | Rhesus macaque |
| Stage: | Assays Completed |
| Study Start Date: | 2009-11-24 |
| Study Made Public: | 2014-10-15 |
Title
Limiting Dose Vaginal SIVmac239 Challenge of RhCMV-SIV vaccinated Indian rhesus macaques.
Description
CAVD 232 is an NHP challenge study comparing a CMV vaccine, RhCMV-SIV, to a control RhCMV vector, and a vaccine-naïve group.
Sign in to see full information about this study and to download study data.
Products
SIVmac239 CMV-SIV Placebo CMV NoneIntegrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.